Biolife Solutions (BLFS) Non-Current Debt (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Non-Current Debt of $2.5 million for Q1 2026, down 80.7% year-over-year from $12.9 million in Q1 2025, and down 49.99% quarter-over-quarter from $5.0 million in Q4 2025.
Biolife Solutions (BLFS) Non-Current Debt (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Non-Current Debt for 13 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt fell 80.7% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 80.7% YoY), while the FY2025 annual figure was $5.0 million, down 68.65% from the prior year.
- Non-Current Debt retreated to $2.5 million in Q1 2026 per BLFS's latest filing, from $5.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $26.3 million in Q3 2022 and bottomed at $2.5 million in Q1 2026.
- Historically, Non-Current Debt has averaged $16.9 million across 5 years, with a median of $20.1 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Debt soared 589.19% — and 2026, when it plunged 80.7%.
- Biolife Solutions' Non-Current Debt stood at $25.6 million in 2022, then sank by 31.42% to $17.6 million in 2023, then retreated by 9.23% to $15.9 million in 2024, then plunged by 68.65% to $5.0 million in 2025, then plunged by 49.99% to $2.5 million in 2026.
- Business Quant data shows BLFS's Non-Current Debt at $2.5 million in Q1 2026, $5.0 million in Q4 2025, and $12.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 12.95 Mn |
| Dec 31, 2024 | 15.94 Mn |
| Sep 30, 2024 | 20.05 Mn |
| Jun 30, 2024 | 21.07 Mn |
| Mar 31, 2024 | 24.30 Mn |
| Dec 31, 2023 | 17.56 Mn |
| Sep 30, 2023 | 20.94 Mn |
| Jun 30, 2023 | 25.51 Mn |
| Mar 31, 2023 | 23.69 Mn |
| Dec 31, 2022 | 25.61 Mn |
| Sep 30, 2022 | 26.27 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | 6.31 Mn |
| Dec 31, 2021 | 6.35 Mn |
| Sep 30, 2021 | 6.12 Mn |
| Jun 30, 2021 | 5.02 Mn |
| Mar 31, 2021 | 916,000.00 |
| Dec 31, 2020 | 655,000.00 |